case_images: PMC11774923_01
case_images: (A-C) First colonoscopy images before treatment showed that multiple telangiectasias were found, especially in the transverse colon and the ascending colon. (D-F) After two courses of Endostar (20 days later), multiple telangiectasias were still observed in the transverse colon and the ascending colon during the colonoscopy, but the magnitude and extent had decreased. (G-I) After four courses of Endostar therapy, the colonoscopy showed that no telangiectasias were found in any segment of the colon.
case_images: fmed-11-1511513-g001.jpg
case_images: PMC11774923_01_fmed-11-1511513-g001.jpg
case_images: fig1
case_images: A colonoscopy was performed to determine the source of the hemorrhage, revealing multiple telangiectasias, primarily located in the transverse and ascending colon (Figures 1A-C). The results showed that while colonic telangiectasias were still present, the magnitude and extent had decreased (Figures 1D-F). Additionally, an erosive bleeding lesion without colonic dilatation was identified and successfully treated with argon plasma coagulation (APC) (Figure 1D). A subsequent colonoscopy showed complete resolution of the telangiectasias in all segments of the colon (Figures 1G-I).
case_images: A timeline of test and treatment.
case_images: fmed-11-1511513-g002.jpg
case_images: PMC11774923_01_fmed-11-1511513-g002.jpg
case_images: fig2
case_images: A review of the diagnosis and treatment timeline is presented in Figure 2.
case_images: Key hematologic parameters from admission to discharge. (A) The trends in hemoglobin (Hb) concentration, red blood cell (RBC) count, and albumin (ALB) concentration. (B) The trends in platelet (PLT) count and white blood cell (WBC) count. (C) A graph of specific values corresponding to the figure.
case_images: fmed-11-1511513-g003.jpg
case_images: PMC11774923_01_fmed-11-1511513-g003.jpg
case_images: fig3
case_images: Key hematologic variables from admission to discharge are shown in Figure 3.